97 related articles for article (PubMed ID: 19959360)
1. SAR of N-phenyl piperidine based oral integrin alpha5beta1 antagonists.
Zischinsky G; Osterkamp F; Vossmeyer D; Zahn G; Scharn D; Zwintscher A; Stragies R
Bioorg Med Chem Lett; 2010 Jan; 20(1):65-8. PubMed ID: 19959360
[TBL] [Abstract][Full Text] [Related]
2. Discovery of orally available integrin alpha5beta1 antagonists.
Zischinsky G; Osterkamp F; Vossmeyer D; Zahn G; Scharn D; Zwintscher A; Stragies R
Bioorg Med Chem Lett; 2010 Jan; 20(1):380-2. PubMed ID: 19910191
[TBL] [Abstract][Full Text] [Related]
3. Design and synthesis of a new class of selective integrin alpha5beta1 antagonists.
Stragies R; Osterkamp F; Zischinsky G; Vossmeyer D; Kalkhof H; Reimer U; Zahn G
J Med Chem; 2007 Aug; 50(16):3786-94. PubMed ID: 17616113
[TBL] [Abstract][Full Text] [Related]
4. Rational design of highly active and selective ligands for the alpha5beta1 integrin receptor.
Heckmann D; Meyer A; Laufer B; Zahn G; Stragies R; Kessler H
Chembiochem; 2008 Jun; 9(9):1397-407. PubMed ID: 18481343
[TBL] [Abstract][Full Text] [Related]
5. Novel derivatives of 2-pyridinemethylamine as selective, potent, and orally active agonists at 5-HT1A receptors.
Vacher B; Bonnaud B; Funes P; Jubault N; Koek W; Assié MB; Cosi C; Kleven M
J Med Chem; 1999 May; 42(9):1648-60. PubMed ID: 10229633
[TBL] [Abstract][Full Text] [Related]
6. Piperidine-containing beta-arylpropionic acids as potent antagonists of alphavbeta3/alphavbeta5 integrins.
De Corte BL; Kinney WA; Liu L; Ghosh S; Brunner L; Hoekstra WJ; Santulli RJ; Tuman RW; Baker J; Burns C; Proost JC; Tounge BA; Damiano BP; Maryanoff BE; Johnson DL; Galemmo RA
Bioorg Med Chem Lett; 2004 Oct; 14(20):5227-32. PubMed ID: 15380233
[TBL] [Abstract][Full Text] [Related]
7. Ligand binding analysis for human alpha5beta1 integrin: strategies for designing new alpha5beta1 integrin antagonists.
Marinelli L; Meyer A; Heckmann D; Lavecchia A; Novellino E; Kessler H
J Med Chem; 2005 Jun; 48(13):4204-7. PubMed ID: 15974570
[TBL] [Abstract][Full Text] [Related]
8. Antagonists of human CCR5 receptor containing 4-(pyrazolyl)piperidine side chains. Part 3: SAR studies on the benzylpyrazole segment.
Shu M; Loebach JL; Parker KA; Mills SG; Chapman KT; Shen DM; Malkowitz L; Springer MS; Gould SL; DeMartino JA; Siciliano SJ; Salvo JD; Lyons K; Pivnichny JV; Kwei GY; Carella A; Carver G; Holmes K; Schleif WA; Danzeisen R; Hazuda D; Kessler J; Lineberger J; Miller MD; Emini EA
Bioorg Med Chem Lett; 2004 Feb; 14(4):947-52. PubMed ID: 15012999
[TBL] [Abstract][Full Text] [Related]
9. Bradykinin B1 antagonists: SAR studies in the 2,3-diaminopyridine series.
Kuduk SD; Chang RK; Ng C; Murphy KL; Ransom RW; Tang C; Prueksaritanont T; Freidinger RM; Pettibone DJ; Bock MG
Bioorg Med Chem Lett; 2005 Sep; 15(17):3925-9. PubMed ID: 15993596
[TBL] [Abstract][Full Text] [Related]
10. Antagonists of human CCR5 receptor containing 4-(pyrazolyl)piperidine side chains. Part 1: Discovery and SAR study of 4-pyrazolylpiperidine side chains.
Shen DM; Shu M; Mills SG; Chapman KT; Malkowitz L; Springer MS; Gould SL; DeMartino JA; Siciliano SJ; Kwei GY; Carella A; Carver G; Holmes K; Schleif WA; Danzeisen R; Hazuda D; Kessler J; Lineberger J; Miller MD; Emini EA
Bioorg Med Chem Lett; 2004 Feb; 14(4):935-9. PubMed ID: 15012997
[TBL] [Abstract][Full Text] [Related]
11. Tricyclic pharmacophore-based molecules as novel integrin alpha(v)beta3 antagonists. Part 1: design and synthesis of a lead compound exhibiting alpha(v)beta3/alpha(IIb)beta3 dual antagonistic activity.
Kubota D; Ishikawa M; Yamamoto M; Murakami S; Hachisu M; Katano K; Ajito K
Bioorg Med Chem; 2006 Apr; 14(7):2089-108. PubMed ID: 16309911
[TBL] [Abstract][Full Text] [Related]
12. Benzoxazole piperidines as selective and potent somatostatin receptor subtype 5 antagonists.
Martin RE; Mohr P; Maerki HP; Guba W; Kuratli C; Gavelle O; Binggeli A; Bendels S; Alvarez-Sánchez R; Alker A; Polonchuk L; Christ AD
Bioorg Med Chem Lett; 2009 Nov; 19(21):6106-13. PubMed ID: 19786348
[TBL] [Abstract][Full Text] [Related]
13. Interaction of cis-(6-benzhydrylpiperidin-3-yl)benzylamine analogues with monoamine transporters: structure-activity relationship study of structurally constrained 3,6-disubstituted piperidine analogues of (2,2-diphenylethyl)-[1-(4-fluorobenzyl)piperidin-4-ylmethyl]amine.
Kolhatkar RB; Ghorai SK; George C; Reith ME; Dutta AK
J Med Chem; 2003 May; 46(11):2205-15. PubMed ID: 12747792
[TBL] [Abstract][Full Text] [Related]
14. Tricyclic pharmacophore-based molecules as novel integrin alpha(v)beta3 antagonists. Part III: synthesis of potent antagonists with alpha(v)beta3/alpha(IIb)beta3 dual activity and improved water solubility.
Ishikawa M; Hiraiwa Y; Kubota D; Tsushima M; Watanabe T; Murakami S; Ouchi S; Ajito K
Bioorg Med Chem; 2006 Apr; 14(7):2131-50. PubMed ID: 16307881
[TBL] [Abstract][Full Text] [Related]
15. Optimisation of pharmacokinetic properties to afford an orally bioavailable and selective V1A receptor antagonist.
Arbuckle W; Baker J; Barn D; Bingham M; Brown A; Buchanan K; Craighead M; Goodwin R; Goutcher S; Kiczun M; Lyons A; Milne R; Montgomery B; Napier S; Presland J; Sloan H; Turnbull Z; Wishart G
Bioorg Med Chem Lett; 2011 Aug; 21(15):4622-8. PubMed ID: 21700453
[TBL] [Abstract][Full Text] [Related]
16. Tricyclic pharmacophore-based molecules as novel integrin alpha(v)beta3 antagonists. Part 2: synthesis of potent alpha(v)beta3/alpha(IIb)beta3 dual antagonists.
Ishikawa M; Kubota D; Yamamoto M; Kuroda C; Iguchi M; Koyanagi A; Murakami S; Ajito K
Bioorg Med Chem; 2006 Apr; 14(7):2109-30. PubMed ID: 16309912
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and structure-activity relationship of 7-azaindole piperidine derivatives as CCR2 antagonists.
Xia M; Hou C; DeMong D; Pollack S; Pan M; Singer M; Matheis M; Murray W; Cavender D; Wachter M
Bioorg Med Chem Lett; 2008 Dec; 18(24):6468-70. PubMed ID: 18990568
[TBL] [Abstract][Full Text] [Related]
18. Synthetic study of VLA-4/VCAM-1 inhibitors: synthesis and structure-activity relationship of piperazinylphenylalanine derivatives.
Saku O; Ohta K; Arai E; Nomoto Y; Miura H; Nakamura H; Fuse E; Nakasato Y
Bioorg Med Chem Lett; 2008 Feb; 18(3):1053-7. PubMed ID: 18160288
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and SAR of pyridazinone-substituted phenylalanine amide alpha4 integrin antagonists.
Gong Y; Kent Barbay J; Kimball ES; Santulli RJ; Carolyn Fisher M; Dyatkin AB; Miskowski TA; Hornby PJ; He W
Bioorg Med Chem Lett; 2008 Feb; 18(4):1331-5. PubMed ID: 18226905
[TBL] [Abstract][Full Text] [Related]
20. Antagonists of human CCR5 receptor containing 4-(pyrazolyl)piperidine side chains. Part 2: Discovery of potent, selective, and orally bioavailable compounds.
Shen DM; Shu M; Willoughby CA; Shah S; Lynch CL; Hale JJ; Mills SG; Chapman KT; Malkowitz L; Springer MS; Gould SL; DeMartino JA; Siciliano SJ; Lyons K; Pivnichny JV; Kwei GY; Carella A; Carver G; Holmes K; Schleif WA; Danzeisen R; Hazuda D; Kessler J; Lineberger J; Miller MD; Emini EA
Bioorg Med Chem Lett; 2004 Feb; 14(4):941-5. PubMed ID: 15012998
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
